Atlas Trials

[¹⁴C] Hydronidone Mass Balance Study

Clinical trial NCT07471217 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07471217
Sponsor
Beijing Continent Pharmaceutical Co, Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis B-related Liver Fibrosis
Start date
2026-04-30
Primary completion
2026-07-30
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.